On Tuesday, October 1, 2019, the Forum for Collaborative Research convened its 6th TAVI Forum meeting in Washington, DC. The goal of the TAVI Forum is to advance the regulatory sciences for the treatment and management of CMV by providing an independent and neutral venue for ongoing multi-stakeholder dialogue.
Materials
Presentations
Session I: CMV Immune and Virologic Monitoring
Can BK virus PCR be a surrogate marker in kidney transplant recipients?
Yoichiro Natori MD, MPH, Miami Transplant Institute/Jackson Health System,
Division of Infectious Diseases, University of Miami
Session II: Adenovirus Infection in Transplantation:
Virologic Surrogates & Clinical Trial Design
FDA Research Opportunities in the Office of Antimicrobial Products
Prabha Viswanathan, MD, Division of Antiviral Products,
Center for Drug Evaluation and Research, FDA
